Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: Pilot study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 3, 2007, Pages 326-334

  Schäffler, Andreas ^a   Landfried, Karin ^a   Völk, Markus ^a   Fürst, Alois ^a   Büchler, Christa ^a   Schölmerich, Jürgen ^a   Herfarth, Hans ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adiponectin; Leptin; Pancreatitis necrosis; Resistin

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; LEPTIN; RESISTIN;

ACUTE PANCREATITIS; ADULT; AGED; APACHE; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PANCREAS NECROSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC;

EID: 33846901416     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04364.x     Document Type: Article

References (43)

1. Mitchell RMS, Byrne MF, Baillie J. Pancreatits. Lancet 2003; 361: 1447-55.
2. Sandberg AA, Borgström A. Early prediction of severity in acute pancreatitis. Is this possible? JOP 2002; 3: 116-25.
3. Bradley EL. Clinically based classification system for acute pancreatitis. Arch. Surg. 1993; 128: 586-90.
4. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223: 603-13.
5. Papachristou GI, Whitcomb DC. Predictors of severity and necrosis in acute pancreatitis. Gastroenterol. Clin. North Am. 2004; 33: 871-90.
6. Sultan S, Baillie J. What are the predictors of post-ERCP pancreatitis, and how useful are they? JOP 2002; 3: 188-94.
7. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am. J. Gastroenterol. 2002; 97: 1309-18.
8. Triester SL, Kowdley KV. Prognostic factors in acute pancreatitis. J. Clin. Gastroenterol. 2002; 34: 167-76.
9. Johnson CD, Toh SKC, Campbel MJ. Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology 2002; 4: 1-6.
10. Knaus WA, Draper EA, Wagner DP, Zimmermann JE. APACHE-II: a severity of disease classification. Crit. Care Med. 1985; 13: 818-29.
11. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of acute pancreatitis ACHE II, clinical assessment and multiple factor scoring systems. Br. J. Surg. 1990; 77: 1260-4.
12. Osborne DH, Imrie CW, Carter DC. Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br. J. Surg. 1981; 68: 758-61.
13. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg. Gynecol. Obstet. 1974; 139: 69-81.
14. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J. Clin. Gastroenterol. 2003; 36: 253-60.
15. Balthazar EJ. Complications of acute pancreatitis: clinical and CT evaluation. Radiol. Clin. North Am. 2002; 40: 1211-27.
16. Schröder T, Kivisaari L, Somer K, Standertskjold-Nordenstamm CG, Kivilaakso E, Lempinen M. Significance of extrapancreatic findings in computed tomography of acute pancreatitis. Eur. J. Radiol. 1985; 5: 273-5.
17. van den Biezenbos AR, Kruyt PM, Bosscha K et al. Added value of CT criteria compared to clinical SAP score in patients with acute pancreatitis. Abdom. Imaging 1998; 23 622-6.
18. Neoptolemos JP, Kemppainen EA, Mayer JM et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-60.
19. Schölmerich J. Interleukins in acute pancreatitis. Scand. J. Gastroenterol. 1996; 219: 37-42.
20. Mentula P, Kylänpää ML, Kemppainen E et al. Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br. J. Surg. 2005; 92: 68-75.
21. Messmann H, Vogt W, Falk W et al. Interleukins and their antagonists but not TNF and its receptors are released in post-ERCP pancreatitis. Eur. J. Gastroenterol. Hepatol. 1998; 10: 611-17.
22. Johnson CD, Lempinen M, Imrie CW et al. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br. J. Surg. 2004; 91: 1027-33.
23. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br. J. Surg. 1989; 76: 177-81.
24. Gan SI, Romagnuolo J. Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig. Dis. Sci. 2004; 49: 1946-52.
25. Lankisch PG, Schirren CA. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 1990; 5: 262-629.
26. Porter KA, Banks PA. Obesity as a predictor of severity in acute pancreatitis. Int. J. Pancreatol. 1991; 10: 247-52.
27. Schäffler A, Schölmerich J, Büchler C. Adipocytokines and visceral adipose tissue. Emerging role in intestinal and mesenteric diseases. Nat. Clin. Prac. (Gastroenterol. Hepatol.) 2005; 2: 103-11.
28. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 1996; 2: 800-3.
29. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000; 11: 327-32.
30. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-82.
31. Arner P. Regional differences in protein production by human adipose tissue. Biochem. Soc. Trans. 2001; 29: 72-5.
32. Otero M, Lago R, Lago F et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005; 579: 295-301.
33. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 2005; 257: 167-75.
34. Steppan CM, Lazar MA. The current biology of resistin. J. Intern. Med. 2004; 255: 439-47.
35. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 2002; 530: 158-62.
36. Schäffler A, Büchler C, Müller-Ladner U et al. Identification of influencing variables on resistin serum levels in patients with diabetes mellitus type 1 and type 2. Horm. Metab. Res. 2004; 36: 702-7.
37. McTernan PG, McTernan CL, Chetty R et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 2002; 87: 2407.
38. Yavuz N, Unal E, Memisoglu K et al. Plasma leptin levels in rats with pancreatitis. Tohoku J. Exp. Med. 2004; 204: 243-8.
39. Konturek PC, Jaworek J, Maniatoglou A et al. Leptin modulates the inflammatory response in acute pancreatitis. Digestion 2002; 65: 149-60.
40. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001; 14: 2565-71.
41. Schäffler A, Herfarth H, Paul G et al. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2. Exp. Clin. Endocrinol. Diab. 2004; 112: 383-9.
42. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003; 14: 561-6.
43. Ouchi N, Kihara S, Arita Y et al. Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through cAMP-dependent pathways. Circulation 2000; 102: 1296-301.